Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for CBGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
August 31, 2019 0.0124M
May 31, 2019
February 28, 2019
November 30, 2018
August 31, 2018
May 31, 2018
February 28, 2018
November 30, 2017
August 31, 2017
May 31, 2017
February 28, 2017
November 30, 2016
August 31, 2016
May 31, 2016
February 29, 2016
November 30, 2015
August 31, 2015
May 31, 2015 0.00
February 28, 2015 0.00
November 30, 2014 0.00
August 31, 2014 0.00
May 31, 2014 0.00
February 28, 2014 0.00
November 30, 2013 0.00
Date Value
August 31, 2013 0.00
May 31, 2013 0.00
February 28, 2013 0.00
November 30, 2012 0.00
August 31, 2012 0.00
May 31, 2012 0.00
February 29, 2012 0.00
November 30, 2011 0.00
August 31, 2011 0.00
May 31, 2011 0.00
February 28, 2011 0.00
November 30, 2010 0.00
August 31, 2010 0.00
May 31, 2010 0.00
February 28, 2010 0.00
November 30, 2009 0.00
August 31, 2009 0.00
May 31, 2009 0.00
February 28, 2009 0.00
November 30, 2008 -0.01M
August 31, 2008 0.00
May 31, 2008 0.02M
February 29, 2008 0.01M
November 30, 2007 0.00

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Filana Therapeutics, Inc. 3.303M
CorMedix, Inc. 6.684M
Eloxx Pharmaceuticals, Inc. 2.84M
Breakthrough Chemistry, Inc. 0.0041M
BioStem Technologies, Inc. 0.7336M